Simplex Trading’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-3
Closed -$1K 7079
2017
Q3
$1K Buy
+3
New +$4 ﹤0.01% 5690
2017
Q2
Sell
-68
Closed -$21K 7178
2017
Q1
$21K Buy
68
+26
+62% +$118 ﹤0.01% 3224
2016
Q4
$1K Buy
+42
New +$221 ﹤0.01% 5639

Simplex Trading's GNMX Position: Q1 2020 in Review

Simplex Trading sold out of Aevi Genomic Medicine Inc (GNMX) in Q1 2020, closing a stake of 100 shares.

Simplex Trading first reported a position in GNMX in Q4 2014 and held it in 12 quarters. The position peaked at $15K in Q4 2015. 2 funds tracked by Wall St. Rank hold GNMX as of Q1 2020.

  • Simplex Trading reported no remaining Aevi Genomic Medicine Inc position as of Q1 2020 after selling out during the quarter.
  • Simplex Trading sold 100 Aevi Genomic Medicine Inc shares in Q1 2020.
  • Simplex Trading first reported a position in Aevi Genomic Medicine Inc in Q4 2014 and held it in 12 quarters.
  • Simplex Trading's Aevi Genomic Medicine Inc position peaked at $15K in Q4 2015.
  • 2 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q1 2020.

Based on Simplex Trading's 13F filing for Q1 2020, filed 29 Apr 2020.